Testosterone: here's the fair price
This is what US pharmacies pay, on average, for testosterone. Use it to spot a fair cash price, and feel good about asking for one.
Testosterone 1% (50 Mg/5 G) Pk
A fair cash price is usually this cost plus a dispensing fee. If your quote is many times higher, ask about a generic, another pharmacy, or a cash discount.
Source: CMS NADAC weekly file as of 2026-11-04. Median across NDCs with the same description. Public domain.
Your ZIP and location stay in your browser. We never store them.
Every strength and form
| Product | Pharmacy cost | 30 count | Effective |
|---|---|---|---|
| TESTOSTERONE 1% (50 MG/5 G) PKGeneric | $0.43 per gram | n/a | 10/21/2026 |
| TESTOSTERONE 50 MG/5 GRAM PKTGeneric | $0.43 per gram | n/a | 10/21/2026 |
| TESTOSTERONE 1.62% GEL PUMPGeneric | $0.47 per gram | n/a | 10/21/2026 |
| TESTOSTERONE 30 MG/1.5 ML PUMPGeneric | $0.54 per mL | n/a | 10/21/2026 |
| TESTOSTERONE 50 MG/5 GRAM GELGeneric | $0.77 per gram | n/a | 10/21/2026 |
| TESTOSTERONE 12.5 MG/1.25 GRAMGeneric | $0.80 per gram | n/a | 10/21/2026 |
| TESTOSTERONE 1% (25 MG/2.5 G) PKGeneric | $1.11 per gram | n/a | 10/21/2026 |
| TESTOSTERONE 1.62% (2.5 G) PKTGeneric | $1.77 per gram | n/a | 10/21/2026 |
| TESTOSTERONE CYP 2,000 MG/10 MLGeneric | $3.52 per mL | n/a | 10/21/2026 |
| TESTOSTERONE 1.62%(1.25 G) PKTGeneric | $4.08 per gram | n/a | 10/21/2026 |
| TESTOSTERONE CYP 1,000 MG/10 MLGeneric | $4.32 per mL | n/a | 10/21/2026 |
| TESTOSTERONE 10 MG GEL PUMPGeneric | $4.55 per gram | n/a | 11/19/2025 |
| TESTOSTERONE CYP 200 MG/MLGeneric | $11.01 per mL | n/a | 10/21/2026 |
| TESTOSTERONE ENAN 200 MG/MLGeneric | $14.48 per mL | n/a | 10/21/2026 |
Source: CMS NADAC, as of 2026-11-04. National average acquisition cost, not a retail quote.
Label basics
What it is used for (FDA label)
INDICATIONS AND USAGE MALES Androgens are indicated for replacement therapy in conditions associated with a deficiency or absence of endogenous testosterone. a. Primary hypogonadism (congenital or acquired) - testicular failure due to cryptorchidism, bilateral torsion, orchitis, vanishing testes syndrome; or orchiectomy. b. Hypogonadotropic hypogonadism (congenital or acquired) - gonadotropic LHRH deficiency, or pituitary - hypothalamic injury from tumors, trauma or radiation. If the above conditions occur prior to puberty, androgen replacement therapy will be needed during the adolescent years for development of secondary sex characteristics. Prolonged androgen treatment will be required...
Common side effects (FDA label)
ADVERSE REACTIONS The following adverse reactions have been identified during post-approval use of testosterone replacement therapy, including TESTOPEL ® . Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. Implantation Site Infection and Pellet Extrusion: (see WARNINGS) Endocrine and Urogenital, Male. Gynecomastia and excessive frequency and duration of penile erections. Oligospermia may occur at high dosages (see CLINICAL PHARMACOLOGY ). Skin...
Warnings (from the label)
WARNINGS In patients with breast cancer, androgen therapy may cause hypercalcemia by stimulating osteolysis. In this case, the drug should be discontinued. Prolonged use of high doses of androgens has been associated with the development of peliosis hepatis and hepatic neoplasms including hepatocellular carcinoma (see PRECAUTIONS - Carcinogenesis, Mutagenesis, Impairment of Fertility). Peliosis hepatis can be a life-threatening or fatal complication. Men treated with androgens may be at an increased risk for the development of prostatic hypertrophy and prostatic carcinoma. There have been postmarketing reports of venous thromboembolic events, including deep vein thrombosis (DVT) and...
Source: FDA drug label via openFDA, label effective 2025-07-17. Full label on DailyMed. Excerpts are verbatim and truncated. Read the full label and ask your pharmacist.